Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Bill Wexler's Profits of DOOM -- Ignore unavailable to you. Want to Upgrade?

To: Hank who wrote (653)	4/10/1998 1:30:00 PM
From: Biojunkie	Respond to of 4634

Hank, Good point. Carl Merril, reported in Jama (2/24/89), that abnormally low DHEAS levels in both healthy HIV+ individuals and patients with AIDS (Ref. W). He concluded that the observations of diminished plasma dehydroepiandrosterone levels in patients infected with HIV and the reports of the protective effects of dehydroepiandersterone in animal and heman cell culture studies suggest that further investigation of the role of dehydroepiandrosterone in HIV infections may be merited. Dr. Mark Jacobson UCSF also reported the correlation in the drop of DHEA levels and the progression to AIDS in HIV positive patients.